Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapy
LOS ANGELES, April 27, 2026 /PRNewswire/ —Â Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation…